A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults
NCT02994381
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
RPC1063
Sponsor
Celgene